Japan on the Move

By Fintan Walton

Pharma Deals Review: Vol 2009 Issue 5 (Table of Contents)

Published: 15 May-2009

DOI: 10.3833/pdr.v2009.i5.1108     ISSN: 1756-7874

Section: Business Commentaries



Japanese pharmaceutical companies are facing a changing healthcare landscape in their domestic markets and are continuing to look for overseas acquisitions for sustained growth. With a reluctance to pay over the odds for acquisitions in the short-term, will Japanese companies pay for it in the long-term.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details